Faculty profile

Daniel Drucker

Back to faculty

ProfessorDepartment of MedicineUniversity of Toronto

Daniel Drucker

Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Scholar ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
No publications on record.
Principal investigator on 14 research grants (12 CIHR, 2 NSERC), most recently in 2025.
Supervisor on 8 trainee awards (8 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Education

MD
Undergraduate Science

Profiles and links

University Profile Personal Website Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Diabetes Metabolism Obesity Gut Endocrine System Peptide Hormones Inflammation Cancer Prevention Atherosclerosis

Latest funding

GLP-1 Receptor Agonists as a Preventive Strategy for Clonal Hematopoiesis-Driven Hematologic Cancers
CIHR · 2025 · Principal investigator
Mechanistic Study of Central Glucagon-like peptide-1 Receptor Signaling in Modulating Systemic Inflammation
CIHR · 2025 · Supervisor
$140,000
Prevention of Adiposity-related Cancers via Biology and Evidence Triangulation (PROBE)
CIHR · 2025 · Principal investigator
$1,999,985

All 23 grants and awards

GLP-1 Receptor Agonists as a Preventive Strategy for Clonal Hematopoiesis-Driven Hematologic Cancers

Principal investigatorCIHR2025Team Grant: Bringing Biology to Cancer Prevention - General Pool

Principal investigators: Chan, Steven M; Drucker, Daniel J; Xie, Stephanie Z

Keywords: Cancer Prevention; Clonal Fitness; Clonal Hematopoiesis; Diabetes; Glp1 Receptor Agonist; Hematological Malignancies; Hematopoietic Stem Cells; Inflammation; Metabolism; Myeloid Neoplasms

Mechanistic Study of Central Glucagon-like peptide-1 Receptor Signaling in Modulating Systemic Inflammation

SupervisorCIHR2025Canada Postdoctoral Research Award (CPRA) program

Principal investigators: Ren, Wenran

Keywords: Central Glp-1 Receptor Signaling; Diabetes And Obesity; Glp-1 Receptor Agonist; Neuro-Immune Regulation; Systemic Inflammation

$140,000

Prevention of Adiposity-related Cancers via Biology and Evidence Triangulation (PROBE)

Principal investigatorCIHR2025Team Grant: Bringing Biology to Cancer Prevention - General Pool

Principal investigators: Hung, Rayjean; Patton, Ian T; Sockalingam, Sanjeev; Drucker, Daniel J; Retnakaran, Ravi R

Keywords: Biological Mechanisms; Cancer Prevention; Circulating Biomarker; Glp-1; Metabolic Health; Obesity; Risk Prediction

$1,999,985

GLP-1 Receptor Agonists: Exploring Adverse Drug Events in Older Adults

Co-investigatorCIHR2025Project Grant - Priority Announcement: Patient-Oriented Research

Principal investigators: Rochon, Paula A; Stall, Nathan M

Keywords: Adverse Drug Events; Aging; Glp-1 Receptor Agonists; Older Women; Ozempic; Rybelsus

$100,000

The anti-inflammatory actions of glucagon-like peptide 1-based medicines in the brain

SupervisorCIHR2025DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

Principal investigators: Fang, Susanna

Keywords: Astrocytes; Central Nervous System; Glucagon-Like Peptide 1; Glucagon-Like Peptide 1-Based Medicines; Lipopolysaccharide; Neuroinflammation; Neurological Disorders; Neurons; Proteomics; Single-Cell Rna Sequencing

$120,000

Role of the vascular smooth muscle GLP-1 receptor in renoprotection

SupervisorCIHR2024CIHR Fellowship

Principal investigators: Medak, Kyle D

Keywords: Diabetes; Glp-1; Hypertension; Kidney; Mice

$210,000

Direct and indirect mechanisms of GLP-1 action

Nominated PICIHR2023Project Grant

Principal investigators: Drucker, Daniel J

Keywords: Atherosclerosis; Diabetes; Gut Hormones; Metabolic Liver Disease; Obesity

$998,325

Elucidating the role of the central nervous system as a metabolic target for new metabolism-regulating drugs acting through the glucose-dependent insulinotropic polypeptide receptor (GIPR)

SupervisorCIHR2023CIHR Fellowship

Principal investigators: Hammoud, Rola

Keywords: Appetite-Control; Central Nervous System; Gipr Agonist And Antagonist Treatments; Glucagon-Like Peptide 1 Receptor (Glp-1r) Agonist; Glucose Tolerance; Glucose-Dependent Insulinotropic Polypeptide Receptor (Gipr); Neuron-Specific Gipr Knockout Mice; Obesity; Peripheral Nervous System; Targeted Drug Therapy

$135,000

Using novel transplantation strategies and HLA-edited hypoimmunogenic hPSCs to develop a superior islet-like product for T1D treatment

Principal investigatorCIHR2020Team Grant: CIHR-JDRF-Accelerating Stem Cell-Based Therapies for Type 1 Diabetes

Principal investigators: Nostro, Maria Cristina; Drucker, Daniel J; Korbutt, Gregory S; Pepper, Andrew R; Vasconcelos, Sara N

Keywords: Beta Cells; Directed Differentiation; Hla-Editing; Human Pluripotent Stem Cells; Humanized Mice; Regenerative Medicine; Transplantation; Type 1 Diabetes

$1,500,000

Immunometabolic roles and therapeutic potential of glucose-dependent insulinotropic polypeptide(GIP)

Nominated PICIHR2019Joint Canada-Israel Health Research Program

Principal investigators: Drucker, Daniel J; Varol, Chen

Keywords: Atherosclerosis; Diabetes; Heart Disease; Inflammation; Obesity

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Profile data last refreshed on September 26, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction